SteadyMed Ltd. STDY
Set alert
At close · Jun 28
- Open
- 4.73
- Prev close
- 4.73
- Mkt cap
- 126.36M
- Vol
- 0
- Avg vol
- 63.84K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.73
- High
- 4.73
- Forward P/E
- -10.27
- Beta
- 0.16
- Short ratio
- 0.38
- Inst. own
- 43.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2018
- 50-d avg
- 4.73
- 200-d avg
- 4.46
- 1y target
- 15.00
Key statistics
- Market cap
- 126.36M
- Enterprise value
- 105.23M
- Trailing P/E
- 0.00
- Forward P/E
- -10.27
- PEG ratio
- 0.00
- Price / sales
- 293.18
- Price / book
- 29.35
- EPS (TTM)
- -0.637
- Beta
- 0.16
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 431.00K
- Revenue growth
- 0.00%
- Free cash flow
- -14.24M
- Total cash
- 21.13M
- Total debt
- 0
- Return on equity
- -140.34%
- Shares outstanding
- 26.74M
- Short % of float
- 0.49%
- 50-day average
- 4.73
- 200-day average
- 4.46
Analyst view
Consensus: buy
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 14, 2018
Expected Aug 14, 2018. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 14, 2018 | Jun 1, 2018 | -0.19 | — | — | — |
| May 15, 2018 | Mar 1, 2018 | -0.20 | — | — | — |
| Mar 30, 2018 | Dec 1, 2017 | -0.47 | — | — | — |
| Nov 13, 2017 | Sep 1, 2017 | -0.46 | — | — | — |
| Aug 11, 2017 | Jun 1, 2017 | -0.40 | — | — | — |
| May 12, 2017 | Mar 1, 2017 | -0.30 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 30, 2018 | JMP Securities | down | Market Outperform | Market Perform |
| Nov 6, 2016 | H.C. Wainwright | init | — | Buy |
| Apr 13, 2015 | RBC Capital | init | — | Outperform |
| Apr 13, 2015 | Wells Fargo | init | — | Outperform |
| Apr 13, 2015 | JMP Securities | init | — | Market Outperform |
About SteadyMed Ltd.
SteadyMed Ltd., together with its subsidiaries, operates as a specialty pharmaceutical company that focuses on the development and commercialization of drug product candidates for the treatment of orphan and high-value diseases with unmet parenteral delivery needs. The company's product candidates are enabled by its proprietary PatchPump, a discreet, water-resistant, and disposable drug administration technology. Its lead drug product candidate is Trevyent that is used for treating pulmonary arterial hypertension. The company also develops two drug product candidates for the treatment of post-surgical and acute pain in the home setting. It has operations in Israel, the United States, and Europe. SteadyMed Ltd. was founded in 2005 and is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- steadymed.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on STDY — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GINOR RON | Director | Stock Award(Grant) | Mar 24, 2015 | 0 |
| NASSIF DAVID W | Chief Financial Officer | Stock Award(Grant) | Nov 12, 2017 | 44,315 |
| RIGBY JONATHAN M N | Chief Executive Officer | Stock Award(Grant) | Dec 27, 2017 | 83,210 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 15.95% | 4,246,196 | 19.11M | Jun 29, 2018 |
| Federated Investors, Inc. | 7.61% | 2,024,936 | 9.11M | Jun 29, 2018 |
| Deerfield Management Company, L.P. (Series C) | 3.45% | 918,120 | 4.13M | Jun 29, 2018 |
| Credit Suisse Ag/ | 2.67% | 710,098 | 3.20M | Jun 29, 2018 |
| Man Group PLC | 2.67% | 710,098 | 3.20M | Jun 29, 2018 |
| Kingdon Capital Management LLC | 1.89% | 503,140 | 2.26M | Jun 29, 2018 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Federated Kaufmann Fund | 4.41% | 1,173,832 | 5.28M | Jun 29, 2018 |
| Federated Kaufmann Small Cap Fund | 1.55% | 413,153 | 1.86M | Jun 29, 2018 |
| Highland Fds I-Highland Long/Short Healthcare Fd | 0.23% | 62,500 | 225.00K | Dec 30, 2017 |
| AMG Managers Essex Small/Micro Cap Growth Fd | 0.13% | 34,725 | 112.86K | Feb 27, 2018 |
| Federated Kaufmann Fund II | 0.11% | 28,534 | 128.40K | Jun 29, 2018 |